The notorious 'Chaddi Baniyan' gang has resurfaced in Malegaon, Nashik, where they targeted six shops, breaking in and stealing goods worth lakhs of rupees. The incident, which took place at around ...

Let's catch up on the latest news from the stock market. From significant investments to major deals, order wins, and appointments, here’s a quick look at which stocks will be in focus in today ...

Global healthcare company GlaxoSmithKline Pharmaceuticals Ltd on Tuesday (September 3) said it has received an income tax refund of ₹222.23 crore for the assessment year 2022-23, following an order ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

An 'underwear' gang has caused a sensation after it broke into a home and a college at Malegaon in Maharashtra's Nashik late last night and stole nearly 70 gm gold -- worth around Rs 5 lakh -- and ...

Given the large stake in the stock by institutions, GSK's stock price might be vulnerable to their trading decisions 51% of the business is held by the top 25 shareholders Insiders have been ...

An elderly man was allegedly assaulted by his co-passengers in an express train near Igatpuri in Maharashtra's Nashik district on suspicion that he was carrying beef. Trending Photos In a disturbing ...

An elderly man named Haji Ashraf Munyar was allegedly beaten by co-passengers in an express train near Igatpuri, Maharashtra, on suspicion of carrying beef. The incident was captured in a video ...

Mumbai: The Ministry of Railways has approved the final location survey for a new broad gauge rail line connecting Nashik and Dahanu, with an estimated cost of Rs. 2.50 crore recently. This 100 ...

Nissan Magnite XV Premium AMT DT Rs. 10.52 Lakh * Nissan Magnite XV Premium DT Rs. 10.53 Lakh * Nissan Magnite Turbo XV Rs. 11.03 Lakh * Nissan Magnite Turbo XV Premium Rs. 11.29 Lakh * Nissan ...

GSK Plc’s RSV vaccine has been approved for wider use in adults in Europe in a boost for the UK company’s blockbuster shot. The European Commission recommended GSK’s Arexvy for adults aged ...